Lanean...

A TRIAL OF SODIUM VALPROATE IN TARDIVE-DYSKINESIA

This study reports the results of an open trial of Sodium Valproate in tardive-dyskinesia. Fifteen patients identified having tardive dyskinesia by two psychiatrists independently were treated with Sodium Valproate in dosage of 1200 mg/day for 4 weeks. Assessments were made on abbreviated Dyskinesia...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Chadda, R., Kulhara, P.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Medknow Publications 1986
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3172504/
https://ncbi.nlm.nih.gov/pubmed/21927146
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!